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Ready, set, wait
 
tem cell differentiation is all about cautious preparation, say Deborah
Lang, Jonathan Epstein (University of Pennsylvania, Philadelphia, PA),
and colleagues. They find that a transcription factor called Pax3 sends
conflicting messages: it gets stem cells ready for the differentiated state, by build-
ing up proteins used in the differentiation program, but inhibits the action of those
differentiation proteins and thus holds the cells back. Only a separate signal can
relieve this repression by Pax3 and unleash the full differentiation program.
“The general concept that there are classes of transcription factors that
yield paradoxical results—both activating and inactivating pathways—has been
around,” says Epstein. “What’s an addition here is a molecular mechanism.”
Epstein’s group came across the phenomenon while studying neural
crest cells. Pax3 was required in mice for the eventual induction of melano-
cyte differentiation markers such as dopachrome tautomerase (Dct), but in
cell culture experiments Pax3 was found to repress Dct expression.
The paradox could be understood based on a series of relationships.
Epstein found that Pax3 helped turn on Mitf, and Mitf was needed to turn on
Dct. But if Pax3 was still around, it could prevent Mitf from binding and
turning on the Dct enhancer. Only when an activated Wnt signal displaced
Pax3 was Mitf able to do its job.
Consistent with this model, only areas positive for Wnt signals were
expressing both Pax3 and Dct. In the embryo, such Wnt-expressing areas
are thought to be terminal migratory locations for neural crest cells. In the
adult, skin damage may generate Wnt signals that prompt the necessary
melanocyte differentiation.
The group suggests that Mitf acts like a “biological capacitor.” It builds up,
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Mice with no fat carriers are skinny
 
he two related fatty acid binding
proteins (FABPs) called aP2 and
mal1 did not seem destined for
fame. “These are seemingly very dull mol-
ecules,” says Gökhan Hotamisligil (Har-
vard School of Public Health, Boston,
MA). “They are like little clams attaching
to fatty acids.” Yet somehow, he says,
these “idle chaperone proteins,” which
shuttle fatty acids around inside the cell,
turn out to “determine lipid metabolism.”
T
Mice lacking both fat carriers (AM
 / ) don’t 
get fat on a high-fat diet.
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but is repressed until needed. Epstein is now looking
for a similar organization in other stem cell systems.
“It’s a tight little circuit,” he says, “and I bet it will
come up again and again.” 
 
Reference: Lang, D., et al. 2005. 
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With Pax3, cells are prepared for but inhibited from 
becoming differentiated (green).
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They may do so by bringing fatty acid
species to regulatory proteins or enzymes.
Mice lacking one or the other FABP
had been generated before by Hotamis-
ligil and shown mild phenotypes. Now
the Boston group, including Kazuhisa
Maeda and Haiming Cao, characterizes
mice lacking both proteins. The mice
have less fat than normal, and after a
high fat diet their body composition,
blood glucose, blood insulin, and insulin
resistance do not worsen but are all indis-
tinguishable from those of wildtype mice
on a normal diet.
The proximal cause of these
changes may be an unusual lipid profile.
The double mutants have more shorter
chain fatty acids in adipocytes and mus-
cle cells, and more longer chain fatty ac-
ids in liver. The results, both in the
mutants and in vitro after similar manipu-
lations of lipid content, include increased
activating phosphorylations of both AMP-
activated kinase (AMP-K) and members
of the insulin receptor pathway in muscle.
AMP-K can induce greater fatty acid oxi-
dation and energy expenditure, as is
seen in the mutant mice. And an acti-
vated insulin receptor pathway would
protect animals from insulin resistance.
FABP acts predominantly in adi-
pose tissue, so the effects on other tissues
must be mediated by other messengers.
Hotamisligil is pursuing these messengers
using cocultures. His “larger aspiration,”
meanwhile, is to “tie FABP to a specific
biological pathway.”
This may involve tracking down lipid
mediators, which is notoriously difficult,
even with the protein now in hand. The al-
tered profile of fatty acids is also not yield-
ing answers easily. The pattern seen in
mutant adipocytes and muscle “has not
been noted as a signature pattern in any
other state” such as fasting or feeding, says
Hotamisligil, so the significance is not im-
mediately clear. He hopes the answer will
come from large-scale “lipomics” efforts to
identify lipid signatures at specific sites and
under specific dietary conditions. 
 
Reference: Maeda, K., et al. 2005. 
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